Novel biomarkers, accepted for early detection of drug-induced AKI including kidney injury molecule-1, neutrophil gelatinase-associated lipocalin and N-acetyl-β-d-glucosaminidase, may be useful additions in panels of biomarkers [33]. Here, HAVCR1 is linked to acute kidney injury.